Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
4(67%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
33%
Ph phase_2
2
33%

Phase Distribution

2

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

6

all time

Status Distribution
Active(4)
Completed(2)

Detailed Status

Recruiting2
Completed2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
6
Active
4
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (50.0%)
Phase 22 (50.0%)

Trials by Status

recruiting233%
completed233%
active_not_recruiting233%

Recent Activity

4 active trials
Showing 5 of 6
completed

Implementation of Online Adaptive Radiotherapy for Breast Cancer Patients on Ethos (BREAST-ART)

NCT05727553
active_not_recruitingphase_1

Online Adaptive Radiotherapy Cervical Cancer With Reduced Margin for Cervical Cancer

NCT05880485
active_not_recruitingphase_1

Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer

NCT05869123
completedphase_2

Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer

NCT05682950
recruitingphase_2

Online Adaptive Radiotherapy for Cervical Cancer

NCT06562166
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05727553

Implementation of Online Adaptive Radiotherapy for Breast Cancer Patients on Ethos (BREAST-ART)

Completed
NCT05880485Phase 1

Online Adaptive Radiotherapy Cervical Cancer With Reduced Margin for Cervical Cancer

Active Not Recruiting
NCT05869123Phase 1

Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer

Active Not Recruiting
NCT05682950Phase 2

Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer

Completed
NCT06562166Phase 2

Online Adaptive Radiotherapy for Cervical Cancer

Recruiting
NCT05438836

Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer

Recruiting

All 6 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
6